Virology News and Research

Latest Virology News and Research

Columbia University professor recommends vaccination for people travelling abroad

Planning to travel outside the U.S. this holiday season? Check with your primary care provider or travel clinic when you book your flight.

16 Oct 2014

Ebola outbreak emphasizes the importance of monitoring disease burden in developing countries

A study recently published in the Journal of the American Academy of Dermatology shows that for Ebola, measles, syphilis and many other conditions with skin manifestations the mortality rates are hundreds of times higher in developing countries than they are in developed countries.

16 Oct 2014

Second Dallas health worker has Ebola; CDC announces 'more robust' response

Seventy-six health-care workers who helped treat Ebola patient Thomas Eric Duncan are now being monitored for potential Ebola exposure. Forty-eight others are being watched because they had contact with Duncan.

16 Oct 2014

Four out of ten children in Burkina Faso genetically resistant to virus strains

Every year rotavirus causes half a million diarrhoea-related deaths amongst children in developing countries. Existing vaccines provide poor protection. The reason could be a widespread genetic resistance amongst children, according to virologists at Linköping University.

15 Oct 2014

Viewpoints: Health law opposition not propelling GOP; keep politics out of the fight against Ebola

As recently as April, Obamacare was going to be the silver bullet for Republicans in this year's midterm elections. The leader of conservative advocacy group Americans for Prosperity said his plan was to make Obamacare "the No. 1 issue in the country." Senate Minority Leader Mitch McConnell, R-Ky., declared that the law would be "a huge disaster in 2014" and the deciding factor in November. Well, that was then. Now, three weeks from Election Day, some GOP challengers trying to knock off Democratic incumbent senators have scaled back their anti-Obamacare ads in favor of new targets such as the economy and national security (10/13).

15 Oct 2014

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has signed an option for a license agreement with the world-renowned German Center for Cancer Research (DKFZ – Deutsches Krebsforschungszentrum), based in Heidelberg. The financial terms of the agreement were not disclosed.

15 Oct 2014

Researchers awarded grant to develop non-invasive device to detect Human Cytomegalovirus

Researchers from Cardiff and Swansea Universities have been awarded a grant of more than £323k to develop a new, non-invasive, low-cost, and easy to use point of care device to diagnose Human Cytomegalovirus (HCMV).

15 Oct 2014

CDC re-evaluating safety procedures after nurse contracts Ebola

Thomas Frieden, the director of the Centers for Disease Control and Prevention, announces that the agency will look again at the protocols for hospitals to see if more training or equipment is necessary to protect health care workers and the public.

15 Oct 2014

TSRI scientists awarded $6.6 million NIH grant to study Lassa fever virus

Scientists from The Scripps Research Institute have been awarded $6.6 million from the National Institutes of Health to lead an investigation of Lassa fever virus, the most prevalent virus-induced hemorrhagic fever disease in Africa.

14 Oct 2014

Ampro Industries spreads HIV/AIDS awareness through "A Positive Message" campaign

It is well known that Ampro Industries, Inc., is a leader when it comes to giving back to the community. The company truly believes in going the extra mile for those who have kept their styling gels number one for decades.

14 Oct 2014

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Johnson & Johnson today announced sales of $18.5 billion for the third quarter of 2014, an increase of 5.1% as compared to the third quarter of 2013. Operational results increased 5.8% and the negative impact of currency was 0.7%. Domestic sales increased 11.6%. International sales decreased 0.3%, reflecting operational growth of 1.0% and a negative currency impact of 1.3%.

14 Oct 2014

Viewpoints: Ebola myths; Sen. McCain's 'opportunistic alarmism'; Gov. Jindal on CDC's misspent resources

Hubris is the greatest danger in wealthy countries - a sort of smug assumption that advanced technologies and emergency-preparedness plans guarantee that Ebola and other germs will not spread. It was hubris that left Toronto's top hospitals battling SARS in 2003, long after the virus was conquered in poorer Vietnam. It was hubris that led the World Health Assembly in 2013 to cut the WHO's outbreak-response budget in favor of more programs to treat cancer and heart disease.

14 Oct 2014

Cornell University researchers reveal details of how MERS-CoV enters host cells

Cornell University researchers have uncovered details of how the deadly Middle East respiratory syndrome coronavirus (MERS-CoV) enters host cells, and offer possible new avenues for treatment.

14 Oct 2014

FDA approves new hepatitis C drug, Harvoni

Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.

14 Oct 2014

Texas health worker contracts Ebola, fueling questions about training and preparedness

The case, the first in which the disease was transmitted in the U.S., raises questions about whether regular hospitals around the country are ready to safely deal with the virus.

13 Oct 2014

Research roundup: Older consumers' spending on health care; hospital leaders' views of reporting quality

In 2011, households with at least one member between ages 50 and 64 spent 8 percent of their total budget on health items, compared with 19 percent for those age 85 or over.

13 Oct 2014

Viewpoints: Effects of health law; conquering Ebola

In case you don't follow me on Twitter, here it is: The Affordable Care Act has already helped slow the rate of growth in health-care costs across the board, putting more money in Americans' pockets and bringing down projected deficits even as millions more people sign up for health insurance and receive access to Medicaid.

13 Oct 2014

Molecular diagnostics and blood screening systems: an interview with Dr Bos and Dr Koppelman

Screening blood donations and molecular diagnostics for patients started in the nineties. At the beginning, the level of automation in molecular diagnostic testing was limited; most of the work had to be done manually.

12 Oct 2014

Social networking strategies encourage more at risk people to get tested for HIV

Old-school face-to-face social networking is a more effective way to identify people with HIV than the traditional referral method, suggests research being presented at IDWeek 2014.

12 Oct 2014

Maker of experimental Ebola drug scales up

The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.

12 Oct 2014

Virology News and Research

Latest Virology News and Research

Columbia University professor recommends vaccination for people travelling abroad

Ebola outbreak emphasizes the importance of monitoring disease burden in developing countries

Second Dallas health worker has Ebola; CDC announces 'more robust' response

Four out of ten children in Burkina Faso genetically resistant to virus strains

Viewpoints: Health law opposition not propelling GOP; keep politics out of the fight against Ebola

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Researchers awarded grant to develop non-invasive device to detect Human Cytomegalovirus

CDC re-evaluating safety procedures after nurse contracts Ebola

TSRI scientists awarded $6.6 million NIH grant to study Lassa fever virus

Ampro Industries spreads HIV/AIDS awareness through "A Positive Message" campaign

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Viewpoints: Ebola myths; Sen. McCain's 'opportunistic alarmism'; Gov. Jindal on CDC's misspent resources

Cornell University researchers reveal details of how MERS-CoV enters host cells

FDA approves new hepatitis C drug, Harvoni

Texas health worker contracts Ebola, fueling questions about training and preparedness

Research roundup: Older consumers' spending on health care; hospital leaders' views of reporting quality

Viewpoints: Effects of health law; conquering Ebola

Molecular diagnostics and blood screening systems: an interview with Dr Bos and Dr Koppelman

Social networking strategies encourage more at risk people to get tested for HIV

Maker of experimental Ebola drug scales up

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation